NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, June 25, 2025 (GLOBE NEWSWIRE) -- Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX:BDI) is pleased to announce that it has entered into an agreement with Raymond James Ltd. as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 4,050,00 ...

Key Takeaways COF's Discover deal and solid card segment support growth despite rising credit risks. Relatively high interest rates are boosting COF's net interest income and net interest margin. COF's rising costs and elevated charge-offs challenge its efficiency and asset quality outlook.Capital One Financial Corporation (COF) remains well-positioned for growth on the back of strategic acquisitions, relatively higher interest rates, a strong balance sheet and a solid Credit Card segment. However, an ele ...

Key Takeaways MCO's top line is supported by analytics growth, acquisitions and strength in bond issuance volumes. Strategic buys like CAPE, Praedicat, and GCR boost diversification and expand global market reach. Elevated expenses from investments, inflation and compliance are expected to pressure profitability.Moody's Corporation’s (MCO) dominant position in the credit rating industry, its revenue diversification efforts and strategic acquisitions will likely continue to support top-line expansion. Howe ...

Key Takeaways THOR approved a new $400M stock repurchase plan, replacing its prior authorization set to expire in July. The RV maker aims to boost value via acquisitions, parts initiatives, and diversified revenue streams. THOR faces margin pressure from weak demand, higher operating costs, and a shrinking global order backlog.THOR Industries, Inc. (THO) , the largest manufacturer of RVs in the world, has retired the company’s prior share repurchase authorization and approved a new authorization. In the l ...

Key Takeaways NVST is expanding globally, boosting access to dental care and seeing growth across key regions. Recent acquisitions like Osteogenics and DEXIS aim to enhance NVST's portfolio and market reach. NVST ended Q1 2025 with $1.08B in cash and low debt, though forex shifts cut sales by 140 bps.Envista Holdings Corp.’s (NVST) global commercial organization expansion positions it for robust future growth due to deeper penetration across more markets. Additionally, it continuously assesses potential b ...

Core Insights - Brown & Brown, Inc. (BRO) shares have increased by 20.4% over the past year, underperforming the industry and Finance sector growth rates of 23.4% and 20.7%, respectively, but outperforming the Zacks S&P 500 composite return of 11.6% [1] - The company has a market capitalization of $30.91 billion, with an average trading volume of 1.8 million shares over the last three months [1] Valuation - BRO shares are trading at a premium with a price-to-forward 12-month earnings ratio of 24.9X, compared to the industry average of 22.71X [4] - Other insurers like Arthur J. Gallagher & Co. (AJG) and Erie Indemnity Company (ERIE) are also trading at multiples higher than the industry average, while Marsh & McLennan Companies, Inc. (MMC) is trading at a discount [4] Growth Projections - The Zacks Consensus Estimate for BRO's 2025 earnings per share indicates an 8.5% year-over-year increase, with revenues projected at $5.20 billion, reflecting an 8.2% improvement [5] - For 2026, the consensus estimates suggest an increase of 8.8% in earnings per share and 8.1% in revenues compared to 2025 [5] - Earnings have grown by 21.5% over the past five years, surpassing the industry average of 15.2% [6] Strategic Initiatives - BRO has completed 687 acquisitions since 1993, leveraging strategic buyouts to capture market opportunities and enhance its product and service portfolio [8][13] - The company has a strong liquidity position supported by its diverse business model and operational expertise [14] - BRO has raised dividends for 30 consecutive years, with a five-year compound annual growth rate (CAGR) of 8.7% [8][15] Analyst Sentiment - Recent bearish sentiment from analysts has led to lowered estimates for 2025 and 2026, with the consensus estimate for 2025 earnings down by 0.4% and for 2026 down by 1.3% over the past 60 days [9] - The average price target from 13 analysts is $119.77 per share, indicating a potential upside of 8.3% from the last closing price [10] Revenue Drivers - Commissions and fees, the main revenue component, benefit from increasing new business, strong retention, and continued rate increases across most coverage lines [12] - The company has met its intermediate annual revenue goal of $4 billion, doubling its revenue in the last five years [12] Conclusion - Factors such as new business, strong retention, rate increases, strategic buyouts, and a solid dividend history position the company well for future growth [16] - The robust capital position reflects financial flexibility, supporting ongoing investments and shareholder returns [16]

Core Insights - Markel Group Inc. (MKL) shares have increased by 21.1% over the past year, outperforming the industry growth of 7.4%, the Finance sector's 19.4%, and the Zacks S&P 500 composite's 11.4% [1][7] - The company has a market capitalization of $24.57 billion and an average trading volume of 0.05 million shares over the last three months [2] - Markel Group's price-to-book ratio stands at 1.48X, significantly lower than the industry average of 6.75X, indicating that its shares are trading at a discount [3] - The stock is currently trading above its 50-day and 200-day simple moving averages, suggesting strong upward momentum [4][8] - The Zacks Consensus Estimate for Markel Group's 2025 earnings per share indicates a year-over-year increase of 16.9%, with revenues expected to reach $15.18 billion, reflecting a 2.4% improvement [9] - Earnings have grown by 23.1% over the past five years, surpassing the industry average growth of 16.2% [10] - The company has been pursuing strategic acquisitions to enhance its insurance operations and grow revenues in Markel Ventures [17] - Markel Group has a share repurchase program authorized for up to $2 billion, with $1.7 billion remaining available for repurchases as of March 31, 2025 [19] Financial Performance - The company has surpassed earnings estimates in three of the last four quarters, with an average beat of 11.26% [2] - The return on equity for Markel Group in the trailing 12 months is 7.48%, which is below the industry average of 36.59% [15] - The company has shown improved premiums and strong retention levels, which are expected to contribute to continued growth [16] Analyst Sentiment - Mixed analyst sentiment exists, with two out of five analysts raising estimates for 2025, while one analyst has lowered estimates for 2026 [11] - The Zacks average price target for MKL shares is $1,879.00, indicating a potential downside of 2.6% from the last closing price [12]

Key Takeaways ZTS gains momentum from flagship drugs like Apoquel, Cytopoint, Simparica Trio and ProHeart 12. Zoetis raised its dividend payout by 16% in 2025, over the previous year. Earnings estimates for 2025 and 2026 continue to rise.Shares of Zoetis (ZTS) have risen 12.5% in a month. The company is a major player in the animal health market. The company operates in seven major product categories, namely, parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical an ...

Key Takeaways HWKN stock has surged 52.8% in a year, sharply outperforming its industry's 1.4% growth. Earnings estimates for HWKN's fiscal 2026 rose 2.6% in 60 days, reflecting stronger growth expectations. Hawkins' Water Treatment segment is poised for strong growth on strategic acquisitions.Hawkins, Inc.’s (HWKN) shares have rallied roughly 31.5% over the past three months. It is benefiting from the strength in its Water Treatment segment and strategic acquisitions.We are positive about HWKN’s prospect ...

Company Overview - Superior Group of Companies, Inc. (SGC) was established in 1920 and operates in three business segments: Healthcare Apparel, Branded Products, and Contact Centers, which serve large, fragmented, and growing markets [2] - The company focuses on creating extraordinary brand engagement experiences for customers and employees through its commitment to service, quality, advanced technology, and omnichannel commerce, providing it with competitive advantages [2] - SGC aims to enhance shareholder value by pursuing a combination of organic growth and strategic acquisitions [2] Upcoming Events - The Chairman, President, and CEO, Michael Benstock, along with CFO Mike Koempel, will participate in a fireside chat at the Sidoti Virtual Investor Conference on June 12, 2025, at 9:15 AM Eastern Time [1] - A live webcast and replay of the event will be available on the company's Investor Relations website [1] - Management will also host virtual meetings throughout the day of the conference [1]